Inc., a global leader focused on improving the health and safety of
people and the environment, today announced an agreement to provide Next
Generation Sequencing (NGS) sample preparation solutions to Macrogen,
Inc., a Korean-based global sequencing company.
As part of the agreement, PerkinElmer will provide Macrogen with its Sciclone®
NGS Workstation for high throughput automated Next Generation
Sequencing sample preparation, the LabChip®
XT nucleic acid size selection and collection system, and the LabChip®
GX nucleic acid separation system, to automate and increase the
company's sequencing analysis efficiency and throughput.
"We are delighted to assist Macrogen in its global mission to help
realize the promise of understanding the human genome through its
services, to advance better therapeutics and diagnostics for clinicians
and patients worldwide," said Kevin Hrusovsky, President, Life Sciences
& Technology, PerkinElmer. "Our next generation sequencing solutions are
well suited for helping to ensure the quality and integrity of genomic
information for use in making personalized medicine a reality."
"Advanced automation-enabling technologies are becoming increasingly
mission critical for effective and efficient interpretation and analysis
of the human genome," said Professor Jeong-Sun Seo, Chairman, Macrogen,
Inc. "By applying PerkinElmer biotechnology solutions, Macrogen will be
able to further strengthen its objective of providing high quality,
best-in-class, next generation sequencing services to researchers and
clinicians all over the world."
"The key to success in leveraging genomic data is the ability to combine
a high degree of accuracy, with efficient high throughput in order to
generate efficiencies leading to lower costs. By assuring quality and
speed through advanced automation for sample preparation and analysis,
we can help provide researchers and clinicians with the insights they
need to revolutionize medical treatment," added Dr. Hyungtae Kim, Chief
Executive Officer, Macrogen, Inc. "We have purchased new NGS sequencers
to meet these demands, which resulted in doubling our sequencing
capacity. In turn, the introduction of these new instruments made it
essential to introduce an advanced automation system, which drove our
decision to select PerkinElmer solutions."
Key features of the PerkinElmer Next Generation Sequencing solutions for
The Sciclone® NGS (Next Generation Sequencing) Workstation
is a complete benchtop solution for library prep, sequence capture,
Creates 480 libraries per week
Performs 192 exome captures per week
Flexibility to run 8-96 samples per run
Support for multiple protocols and kits
Sequence capture, mRNA-Seq, ChIP-Seq
Sample indexing and normalization
The LabChip® GX system offers quick and accurate analysis
of RNA and DNA samples.
Complete assessment of RNA quality for better gene expression data
Exact sizing and quantitation of DNA fragments
Extreme accuracy with resolution down to 5 bp and sensitivity of
Flexible with 96 and 384 well compatibility
Comprehensive and quantitative analysis with LabChip GX software
The LabChip® XT fractionation system performs fast,
automated nucleic acid fractionation accurately and reproducibly.
Reduces wasted "non-aligned" reads with tight size selection
Increases average read length by excluding shorter fragment
Faster sample processing maximizes use of sequence
Reduces waste and exposure to potentially harmful reagents
Fast, reproducible, high resolution DNA size selection